Novartis AG (NVS)
167.58
+2.88
(+1.75%)
USD |
NYSE |
Feb 24, 13:23
Novartis Market Cap : 319.77B for Feb. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Roche Holding AG | 387.05B |
| Amgen, Inc. | 205.20B |
| AstraZeneca PLC | 322.23B |
| Gilead Sciences, Inc. | 183.66B |
| Regeneron Pharmaceuticals, Inc. | 82.21B |
Market Cap Related Metrics
| PE Ratio | 23.32 |
| PS Ratio | 5.978 |
| PEG Ratio | 1.034 |
| Price to Book Value | 6.932 |
| Price to Free Cash Flow | 21.35 |
| Price | 167.58 |
| Earnings Yield | 4.29% |
| PEGY Ratio | 0.9338 |
| Operating PE Ratio | 19.18 |
| Normalized PE Ratio | 22.18 |